Disease Info Card

Iron Metabolism Disorders

Information about Iron Metabolism Disorders: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Iron Metabolism Disorders

Most recent studies have shown that Iron Metabolism Disorders shares some biological mechanisms with anemia, cataract, ceruloplasmin-deficiency, diabetes-mellitus, dominant-hyperferritinemia-and-cataract, hemochromatosis, hereditary-diseases, hereditary-hemochromatosis, hypochromic-anemia, inflammation, iron-deficiency, iron-deficiency-anemia, iron-overload, liver-cirrhosis, liver-diseases, malignant-neoplasms, metabolic-diseases, nerve-degeneration, neurodegenerative-disorders, parkinson-disease.

Among the many pathways, these few ones have gauged particular interests from scientists studying Iron Metabolism Disorders, and have been seen in publications frequently: Aging, Cell Death, Cell Proliferation, Dna Amplification, Electron Transport, Excretion, Immune Response, Inflammatory Response, Intestinal Absorption, Lactation, Localization, Menstruation, Myelination, Oxygen Transport, Pathogenesis, Pigmentation, Response To Erythropoietin, Secretion, Translation, Transport

Quite a number of genes have been found to play important roles in Iron Metabolism Disorders, such as ACO1, CP, EPO, FTL, HAMP, HEPH, HFE, HMOX1, IL6, PANK2, SLC11A2, SLC40A1, TF, TFR2, TMPRSS6. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.